By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Corbus Pharmaceuticals, Inc.  

100 River Ridge Drive

Norwood  Massachusetts  02062   U.S.A.
Phone: 617-963-0100 Fax: 617-663-6085



Company News
Did Corbus (CRBP) Investors Get Thrown Off By A Red Herring? 4/11/2017 6:57:34 AM
Corbus (CRBP) To Commence Single Phase III Study Of Anabasum For Treatment Of Systemic Sclerosis Following Guidance Received From Successful End-Of-Phase II Meeting With FDA 4/5/2017 9:35:10 AM
Tiny Massachusetts Phenom Corbus (CRBP) Plunges Despite Reporting Positive Phase II CF Data 3/30/2017 5:59:54 AM
The Hype Behind Massachusetts Biotech Corbus (CRBP)' Sole Pipeline Drug 3/17/2017 6:34:20 AM
Corbus (CRBP) To Present Gene Expression Data From Recent Phase II Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation And Fibrosis Pathways 3/8/2017 10:11:03 AM
Corbus (CRBP) Announces $27.2 Million Registered Direct Offering 2/28/2017 1:43:34 PM
Corbus (CRBP) Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation In Alveolar Macrophages From Cystic Fibrosis Patients 2/24/2017 12:17:01 PM
Corbus (CRBP) Release: Pharma Receives Orphan Designation For JBT-101 For The Treatment Of Systemic Sclerosis In The European Union 1/17/2017 11:39:16 AM
Why Corbus (CRBP)' Stock Rocketed 412% Upwards in 2016 1/17/2017 8:49:07 AM
Why Massachusetts’ Corbus (CRBP) Keeps a ‘Remarkably Young Staff’—And How it Plans to Double Headcount 12/8/2016 6:30:43 AM